Authors:
Secchi, A
Leonardi, A
Discepola, M
Deschenes, J
Abelson, MB
Citation: A. Secchi et al., An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: Reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis, ACT OPHTH S, 78, 2000, pp. 48-51
Citation: Mn. Artal et al., A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%, ACT OPHTH S, 78, 2000, pp. 64-65
Authors:
Butrus, S
Greiner, JV
Discepola, M
Finegold, I
Citation: S. Butrus et al., Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution inthe human conjunctival allergen challenge model, CLIN THER, 22(12), 2000, pp. 1462-1472
Citation: M. Discepola et al., Comparison of the topical ocular antiallergic efficacy of emedastine 0.05%ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis, ACT OPHTH S, 77, 1999, pp. 43-46
Citation: J. Deschenes et al., Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model, ACT OPHTH S, 77, 1999, pp. 47-52